Professor Alexanian was born in New York City in 1932. He graduated from Dartmouth College, and attended Dartmouth Medical School, and went on to graduate from Harvard Medical School. He did postgraduate training at King County Hospital in Seattle Washington, and the University of Washington School of Medicine and was a Research Fellow in Medicine (Hematology) at the University of Washington, as well as a Research Fellow in Radiobiology at Christie Hospital and Holt Radium Institute in Manchester, England.
Professor Alexanian has held many professional appointments, and administrative responsibilities, including Ashbel Smith Professor of Hematology at the University of Texas, Chairman of the Protocol Review Committee, Chairman of the Multiple Myeloma Committee, Southwest Oncology Group, Periodic Consultant to National Cancer Institute, and a member of the Medical Practice Committee, to name a few.
Professor Alexanian holds numerous honors, among them Capodistrias medal for medical research, University of Athens, Greece, 1990, and he is listed in "Marquis Who's Who in America", "Marquis Who's Who in Cancer", "The Best Doctors in America". Professor Raymond Alexanian Received the Waldenström Award for his work in myeloma research. He is on the editorial board of the American Journal of Hematology and is a reviewer of numerous manuscripts on plasma cell dyscrasias for medical journals. Dr. Alexanian has held offices and been a member in many societies including; Chairman of the American Society of Hematology's education programs on myeloma and aplastic anemia. Chairman of the Gulf Coast Hematology Society, and was President of the Houston Society of Internal Medicine. Dr. Alexanian is on the Scientific Advisory Board of the International Myeloma Foundation.